Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 17,045 | 30,913 | 19,330 | 15,375 | 19,279 |
| TOTAL | $17,045 | $30,913 | $19,330 | $15,375 | $19,279 |
| Non-Current Assets | |||||
| PPE Net | 547,822 | 546,890 | 539,513 | 531,385 | 520,009 |
| Investments And Advances | 15,384 | 16,694 | 19,910 | 24,597 | 25,637 |
| Other Non-Current Assets | 91,214 | 80,159 | 80,581 | 75,980 | 78,099 |
| TOTAL | $654,420 | $643,743 | $640,004 | $631,962 | $623,745 |
| Total Assets | $671,465 | $674,656 | $659,334 | $647,337 | $643,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 45,789 | 38,664 | 21,062 | 21,164 | 39,679 |
| Accounts payable and accrued liabilities | 14,385 | 23,286 | 21,237 | 20,992 | 17,438 |
| Accrued Expenses | 12,629 | 7,763 | 8,152 | 6,471 | 9,526 |
| TOTAL | $85,873 | $79,109 | $59,956 | $56,031 | $77,860 |
| Non-Current Liabilities | |||||
| TOTAL | $132,210 | $122,845 | $122,465 | $117,956 | $116,077 |
| Total Liabilities | $218,083 | $201,954 | $182,421 | $173,987 | $193,937 |
| Shareholders' Equity | |||||
| Common Shares | 171,577 | 54,140 | 131,807 | 135,922 | 139,363 |
| TOTAL | $171,577 | $97,145 | $131,807 | $135,922 | $139,363 |
| Total Liabilities And Equity | $389,660 | $299,099 | $314,228 | $309,909 | $333,300 |